Yu-Jing Liang

856 total citations
38 papers, 424 citations indexed

About

Yu-Jing Liang is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, Yu-Jing Liang has authored 38 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Otorhinolaryngology, 19 papers in Surgery and 16 papers in Oncology. Recurrent topics in Yu-Jing Liang's work include Head and Neck Cancer Studies (26 papers), Head and Neck Surgical Oncology (13 papers) and Lung Cancer Treatments and Mutations (7 papers). Yu-Jing Liang is often cited by papers focused on Head and Neck Cancer Studies (26 papers), Head and Neck Surgical Oncology (13 papers) and Lung Cancer Treatments and Mutations (7 papers). Yu-Jing Liang collaborates with scholars based in China, Germany and Singapore. Yu-Jing Liang's co-authors include Lin‐Quan Tang, Qiuyan Chen, Shanshan Guo, Li‐Ting Liu, Qing‐Nan Tang, Sai‐Lan Liu, Xiaoyun Li, Yue‐Feng Wen, Haojun Xie and Jin‐Jie Yan and has published in prestigious journals such as Journal of Clinical Oncology, Water Research and Cancer Research.

In The Last Decade

Yu-Jing Liang

32 papers receiving 420 citations

Peers

Countries citing papers authored by Yu-Jing Liang

Since Specialization

Citations

This map shows the geographic impact of Yu-Jing Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Jing Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Jing Liang more than expected).

Fields of papers citing papers by Yu-Jing Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Jing Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Jing Liang. The network helps show where Yu-Jing Liang may publish in the future.

Co-authorship network of co-authors of Yu-Jing Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Jing Liang. A scholar is included among the top collaborators of Yu-Jing Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Jing Liang. Yu-Jing Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and optimal duration of maintenance immunotherapy following systemic chemoimmunotherapy and locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A multicenter retrospective cohort study 2025 ·International Journal of Cancer ·(unknown), Tianzhu Lu, (unknown), Bijuan Chen, (unknown), Jingao Li, Xiaochang Gong, Hui Li, Ying‐Ying Huang, Nian Lu, Yu-Jing Liang, Liang‐Ru Ke, Chuanmiao Xie	1
2	Oral administration of TNF-α-modulating probiotics integrated by dual-layered microcapsule for effective treatment of inflammatory bowel disease 2025 ·Chemical Engineering Journal ·(unknown), Yu-Jing Liang, (unknown), (unknown), Ranran Zhang, Liping Gao, Lihong Fan, (unknown), (unknown), Chaoran Yang, Fuan Wang, (unknown), (unknown)	0
3	Reproduction outcomes and prognostic significance of pregnancy after nasopharyngeal carcinoma treatment 2025 ·Annals of Medicine ·(unknown), (unknown), (unknown), Yu-Jing Liang, (unknown), Sai‐Lan Liu, Xiaoyun Li, Chuanmiao Xie, (unknown), Qiuyan Chen, Shanshan Guo, Hai‐Qiang Mai	0
4	Stomata as the Main Pathway for the Penetration of Atmospheric Particulate Matter Pb into Wheat Leaves 2025 ·Toxics ·Ke Zhang, Yu-Jing Liang, Chuang Ma, (unknown), (unknown), Aihua Gao, Nan Liu, Hongzhong Zhang	0
5	Optimal induction chemotherapy courses in nasopharyngeal carcinoma in the IMRT era: A recursive partitioning risk stratification analysis based on EBV DNA and AJCC staging 2025 ·Oral Oncology ·Yu-Jing Liang, (unknown), (unknown), Pan Wang, (unknown), Hai‐Qiang Mai, (unknown)	1
6	Comparison of long-term quality of life and their predictors in survivors between paediatric and adult nasopharyngeal carcinoma in the intensity-modulated radiotherapy era 2024 ·BMC Cancer ·Jing Jin, Shanshan Guo, Liting Liu, (unknown), (unknown), Jie‐Yi Lin, Siqi Liu, Xue-Song Sun, Yu-Jing Liang, (unknown), Hai-Qiang Mai, Qiuyan Chen	0
7	Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma 2022 ·BMC Cancer ·Shanshan Guo, (unknown), Liting Liu, (unknown), Yu-Jing Liang, (unknown), Jing Jin, Lin‐Quan Tang, Hai‐Qiang Mai, Qiuyan Chen	3
8	The Prognostic Role of Plasma Epstein-Barr Virus DNA Levels in the Middle of Intensity Modulated Radiation Therapy to Guide Cisplatin Dose Recommendation in Concurrent Chemoradiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma: A Large Cohort Study 2022 ·Advances in Radiation Oncology ·Zhen‐Chong Yang, Chaochao Du, Li‐Ting Liu, Yu-Jing Liang, Lin‐Quan Tang, Qiuyan Chen, Hai‐Qiang Mai, Shanshan Guo	2
9	Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study 2022 ·European Radiology ·Zhen‐Chong Yang, Yingying Hu, Li‐Ting Liu, Shanshan Guo, Chaochao Du, Yu-Jing Liang, Qiuyan Chen, Hai‐Qiang Mai	2
10	Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma 2022 ·European Journal of Nuclear Medicine and Molecular Imaging ·Xun Zhao, Yu-Jing Liang, Xu Zhang, (unknown), Wei Fan, Lin‐Quan Tang, Di Dong, Jie Tian, Hai‐Qiang Mai	29
11	Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [18F]FDG PET/CT parameters 2022 ·European Radiology ·(unknown), Li‐Ting Liu, Yu-Jing Liang, (unknown), (unknown), (unknown), (unknown), Mei‐Ling Chen, Ning Kang, Hai‐Qiang Mai, (unknown), Qiuyan Chen	7
12	Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study 2021 ·Cancer Biology and Medicine ·(unknown), Shanshan Guo, Li‐Ting Liu, Qiuyan Chen, Yu-Jing Liang, Sai‐Lan Liu, Xuesong Sun, Qing‐Nan Tang, Xiaoyun Li, Ling Guo, Hao‐Yuan Mo, (unknown), (unknown)	8
13	Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study 2021 ·Annals of Translational Medicine ·Qing‐Nan Tang, (unknown), Xiaoqing Sun, Shanshan Guo, Li‐Ting Liu, Yue‐Feng Wen, Sai‐Lan Liu, Haojun Xie, Yu-Jing Liang, Xuesong Sun, Xiaoyun Li, Jin‐Jie Yan, Jin‐Hao Yang, (unknown), Ling Guo, Lin‐Quan Tang, Qiuyan Chen, Hai‐Qiang Mai	15
14	Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma 2021 ·Radiotherapy and Oncology ·Jin‐Jie Yan, Shanshan Guo, Da-Feng Lin, Li‐Ting Liu, Sai‐Lan Liu, Bei-Bei Xiao, Jin‐Hao Yang, (unknown), Zhen‐Chong Yang, Yu-Jing Liang, Qing‐Nan Tang, Chao Lin, Xiaoyun Li, Xue-Song Sun, Jibin Li, Lin‐Quan Tang, Qiuyan Chen, Hai‐Qiang Mai	1
15	Management of suboptimal response to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Re-induction therapy or direct to Radiotherapy? 2021 ·Radiotherapy and Oncology ·Ting Liu, Li‐Ting Liu, Jie‐Yi Lin, Bowen Shen, Shanshan Guo, Sai‐Lan Liu, Xue-Song Sun, Yu-Jing Liang, (unknown), Xiaoyun Li, Qiuyan Chen, Lin‐Quan Tang, Hai‐Qiang Mai	10
16	Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma 2020 ·Therapeutic Advances in Medical Oncology ·Li‐Ting Liu, Yu-Jing Liang, Shanshan Guo, Hao‐Yuan Mo, Ling Guo, Yue‐Feng Wen, Haojun Xie, Qing‐Nan Tang, Xue-Song Sun, Sai‐Lan Liu, Xiaoyun Li, Jin‐Hao Yang, Zhen‐Chong Yang, Lin‐Quan Tang, Qiuyan Chen, Hai‐Qiang Mai	6
17	Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level 2020 ·BMC Cancer ·Sai‐Lan Liu, Xuesong Sun, Haojun Xie, Qiuyan Chen, Huan‐Xin Lin, Hu L, Yu-Jing Liang, Xiaoyun Li, Jin‐Jie Yan, Chao Lin, Zhen‐Chong Yang, Shanshan Guo, Li‐Ting Liu, Qing‐Nan Tang, (unknown), Lin‐Quan Tang, Ling Guo, Hai‐Qiang Mai	13
18	Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response 2019 ·Radiotherapy and Oncology ·Sai‐Lan Liu, Xue-Song Sun, Jin‐Jie Yan, Qiuyan Chen, Huan‐Xin Lin, Yue‐Feng Wen, Shanshan Guo, Li‐Ting Liu, Haojun Xie, Qing‐Nan Tang, Yu-Jing Liang, Xiaoyun Li, Chao Lin, (unknown), Zhen‐Chong Yang, Bei-Bei Xiao, Jin‐Hao Yang, Lin‐Quan Tang, Ling Guo, Hai‐Qiang Mai	51
19	Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis 2018 ·Cancer Research and Treatment ·Yang Li, Lin‐Quan Tang, Li‐Ting Liu, Shanshan Guo, Yu-Jing Liang, Xuesong Sun, Qing‐Nan Tang, Jin‐Xin Bei, Jing Tan, Shuai Chen, Jun Ma, Chong Zhao, Qiuyan Chen, Hai‐Qiang Mai	17
20	The incidence and predictors of symptomatic venous thromboembolism associated with peripherally inserted central catheters in patients with nasopharyngeal carcinoma 2018 ·OncoTargets and Therapy ·Yu-Jing Liang, Yan He, Jian‐Mei Li, (unknown), (unknown), Cong Wang, Lü Ji, (unknown), Lin‐Quan Tang, Qiuyan Chen, Yuying Fan, Wen Hu	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact